The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial.

被引：0
|
作者：
Yano, Toshiro
Togo, Masanori
Nogami, Yoshihide
Takeuchi, Tsutomu
Koike, Takao
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Saitama Med Ctr, Dept Internal Med 2, Kawagoe, Saitama, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [1] Impact of age on outcomes of Japanese patients with rheumatoid arthritis treated with infliximab: The post marketing surveillance trial.
    Dabbous, O.
    Rahman, M. I.
    Gilmer, K.
    Yano, T.
    Nogami, Y.
    Arjunji, R.
    Thompson, H.
    Tang, B.
    Takeuchi, T.
    Koike, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S421 - S421
  • [2] Impact of gender on outcome of Japanese patients with rheumatoid arthritis: The post marketing surveillance trial.
    Dabbous, O.
    Rahman, M. I.
    Gilmer, K.
    Yano, T.
    Nogami, Y.
    Arjunji, R.
    Thompson, H.
    Tang, B.
    Takeuchi, T.
    Koike, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S55 - S55
  • [3] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Tamura, N.
    Kuwana, M.
    Atsumi, T.
    Takei, S.
    Harigai, M.
    Fujii, T.
    Matsuno, H.
    Mimori, T.
    Momohara, S.
    Yamamoto, K.
    Nomura, K.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    Takagi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1408 - 1408
  • [5] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Mimori, T.
    Harigai, M.
    Atsumi, T.
    Kuwana, M.
    Takei, S.
    Tamura, N.
    Fuji, T.
    Matsuno, H.
    Momohara, S.
    Yamamoto, K.
    Kokubo, T.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
  • [6] Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Kawai, Shinichi
    Yamamoto, Kazuhiko
    Harigai, Masayoshi
    Ishida, Kota
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 8 - 16
  • [7] Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
    Takeuchi, T.
    Tatsuki, Y.
    Nogami, Y.
    Ishiguro, N.
    Tanaka, Y.
    Yamanaka, H.
    Kamatani, N.
    Harigai, M.
    Ryu, J.
    Inoue, K.
    Kondo, H.
    Inokuma, S.
    Ochi, T.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 189 - 194
  • [8] Influence of the dose of MTX on the safety and efficacy profile of infliximab treatment in the post-marketing surveillance study (PMS) in Japan
    Takeuchi, T.
    Tatsuki, Y.
    Murakami, S.
    Nogami, Y.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 190 - 190
  • [9] Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: A 2-year post-marketing surveillance study
    Tanaka, Yoshiya
    Mizutani, Hideki
    Fujii, Kunimitsu
    Okubo, Naoki
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 927 - 935
  • [10] Results of a German post-marketing surveillance study to evaluate the effectiveness and safety of the TNF-alpha antibody infliximab in the treatment of patients with rheumatoid arthritis
    Tony, H
    Kneitz, C
    Richter, C
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 272 - 272
12345